Biotechnology startup

Orexia

Orexia aims to develop orally administered orexin positive modulators for the treatment of neurological diseases.

Listed

Biotechnology

Biotechnology in the same market

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Orexia in front of investors. Or tell us what we have wrong.